T0	Outcomes 621 649	flow-mediated dilation (FMD)
T1	Outcomes 654 699	isosorbide dinitrate (ISDN)-mediated dilation
T2	Outcomes 859 905	clinical characteristics, endothelial function
T3	Outcomes 910 931	inflammatory markers.
T4	Outcomes 970 973	FMD
T5	Outcomes 1099 1121	ISDN-mediated dilation
T6	Outcomes 1213 1237	reduced malondialdehyde.
T7	Outcomes 1248 1270	myeloperoxidase levels
T8	Outcomes 1441 1466	CRP nor fibrinogen levels
T9	Outcomes 1619 1702	oxidative stress, improves endothelial function, ameliorates myeloperoxidase levels